Catalyst Wire Dossier Catalyst Wire Dossier

Rubitecan

9-aminocamptothecin · Astex Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rubitecan, covering 2024-08-02 to 2024-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Rubitecan in Cancer Patients With Renal or Hepatic Dysfunction [Phase 1]

See pricing